Viewing Study NCT01266902


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-02-03 @ 8:15 AM
Study NCT ID: NCT01266902
Status: COMPLETED
Last Update Posted: 2021-03-04
First Post: 2010-12-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1
Sponsor: Janssen R&D Ireland
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV-1 Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 Infection View
None HIV-1 View
None HIV View
None TMC278-TiDP6-C222 View
None TMC278-C222 View
None TMC278 View
None Rilpivirine View